Skip to content

Children With Diabetes at Risk for Heart Disease.

Identifying Children With Diabetes Type 1 at High Risk for Cardiovascular Disease.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02275091
Enrollment
240
Registered
2014-10-27
Start date
2014-10-31
Completion date
2020-10-31
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications, Diabetes Mellitus, Type 1

Keywords

Children, Cholesterol

Brief summary

Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients with DM1 younger than 40 years of age and up to 35% of all persons with DM1 will die before age 55 from CVD. Strategies are needed to help identify adolescents with DM1 at risk for CVD so that interventions to prevent heart disease and stroke can be undertaken.

Detailed description

Patients with type 1 diabetes and healthy controls will have evaluation of their lipid profile. Arterial stiffness, heart rate variability and adiposity measurements will be done in patients with type 1 diabetes and healthy controls. Blood pressure and heart rate will be recorded. 50 ml of urine will be collected from patients and controls. All studies will be performed as a single outpatient visit at Georgetown University.

Interventions

None listed

Sponsors

Howard University
CollaboratorOTHER
Georgetown University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

Diabetes type 1 or Healthy

Exclusion criteria

Taking medications that lower cholesterol Duration of type 1 diabetes \< 1 year.

Design outcomes

Primary

MeasureTime frameDescription
small LDL particlesThis is an observational cross sectional study. Samples will be collected through study completion, on average of 6 years duration.Blood test, based on NMR

Countries

United States

Contacts

Primary ContactEvgenia Gourgari, MD
2024441210
Backup ContactKathryn Turner
2024442639

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026